Source: By IndependentOo, Dominik from Germany, Maximilian IV, Laitche, NASA; composite artwork by Belbury - CC BY 4.0, Wikimedia Working in his lab at the pharmaceutical company Sandoz in 1938 ...

The extended-release delivery coupled with the 351mg dose allows for single-dose initiation. Erzofri ® (paliperidone palmitate) extended-release injectable suspension is now available for the the ...

The Brooklyn maniac who brutally slashed four young girls with a meat cleaver is still clinging to life after undergoing emergency surgery — as sources revealed that he had been hospitalized for ...

Luye Pharma Group today announced that ERZOFRI® extended-release injectable suspension is now available for commercial sale in the U.S. for the treatment of adults with schizophrenia and as a ...

Spinogenix announced open enrollment for its Phase II trial of SPG302, the first synaptic regenerative therapy for schizophrenia. According to the company, the launch of the Phase II trial comes amid ...

Schizophrenia affects approximately 0·7% of the global population during their lifetime, including 0·32% of the population at any one time, and imposes a significant health-care burden worldwide. 1–4 ...

Schizophrenia on the other hand is a distinct ... repetitive actions and catatonia. Catatonia is remaining motionless for prolonged periods. The negative symptoms present with loss of normal ...

Death by suicide is more common among schizophrenia patients with an early discharge from in-patient care and under the care of Crisis Resolution/Home Treatment. Individuals who died by suicide ...

for the treatments of acute bipolar I disorder and schizophrenia. The NDA is supported by several clinical studies assessing the efficacy and safety of Bysanti™. Vanda Logo (PRNewsfoto/Vanda Pha ...